Welcome to LookChem.com Sign In|Join Free
  • or
3α-tetrahydropyranyl hydroxy-6α-ethyl-7-keto-5β-cholan-24-oic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1000310-89-3

Post Buying Request

1000310-89-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1000310-89-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1000310-89-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,3,1 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1000310-89:
(9*1)+(8*0)+(7*0)+(6*0)+(5*3)+(4*1)+(3*0)+(2*8)+(1*9)=53
53 % 10 = 3
So 1000310-89-3 is a valid CAS Registry Number.

1000310-89-3Downstream Products

1000310-89-3Relevant academic research and scientific papers

A method for preparing obeticholic acid and related compound

-

, (2017/08/28)

This invention provides a new method for preparing obeticholic acid which belongs to the technical field of medicine. Its raw material is E/2 -3alpha-hydroxy-b-ethylidene-keto-5beta-cholane-24-acid methyl ester(OB-4)which can be gained easily. First, OB-3 can be produced through hydroxy-protection with tetra hydropyrane protecting group. Then, OB-2 can be produced through hydrogenation-reduction in alkaline aqueous solution. Then, OB-1 can be produced through reducing again. At last, the target product--obeticholic acid can be got through catalyzing and removing tetrahydropyrane. The method is simple in production process, the content of isomer impurity is low, and the method is a new synthetic method of obeticholic acid suitable for industrial production.

Treatment of Pulmonary Disease

-

, (2014/06/11)

The present invention relates to methods of treating, reducing the risk of preventing, or alleviating a symptom of a pulmonary disease or condition, reducing or suppressing inflammation in the lung, and promoting lung repair, by using a compound of formula A: or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1000310-89-3